smscall
logo
Pharma & Healthcare

Published On: Jun 3, 2025

Global Mebeverine Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

  • starstarstarstarstar
  • 0
  • 0 Reviews
  • 193 Pages
  • 0 Views

Version Type

$3,950.00

Summary
According to APO Research, The global Mebeverine market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Mebeverine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Mebeverine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The China market for Mebeverine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Mebeverine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Mebeverine include Aurovitas Pharma, Berlin Pharmaceutical, Dr. Reddy's, Eipico Pharmaceutical, Expanscience, Greville Investing Limited, Pharco, Puren Pharma and Sopharma, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Mebeverine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Mebeverine, also provides the sales of main regions and countries. Of the upcoming market potential for Mebeverine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Mebeverine sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Mebeverine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Mebeverine sales, projected growth trends, production technology, application and end-user industry.
Mebeverine Segment by Company
Aurovitas Pharma
Berlin Pharmaceutical
Dr. Reddy's
Eipico Pharmaceutical
Expanscience
Greville Investing Limited
Pharco
Puren Pharma
Sopharma
Swiss Pharm
USV Private Limited
Mylan
Abbott
Mebeverine Segment by Type
Capsule
Tablet
Mebeverine Segment by Application
On-line
Drug Store
Hospital
Mebeverine Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mebeverine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Mebeverine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mebeverine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Mebeverine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Mebeverine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Mebeverine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Mebeverine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
Table 1:Mebeverine Industry Trends
Table 2:Mebeverine Industry Drivers
Table 3:Mebeverine Industry Opportunities and Challenges
Table 4:Mebeverine Industry Restraints
Table 5:Global Mebeverine Revenue by Manufacturers (US$ Million) & (2020-2025)
Table 6:Global Mebeverine Revenue Market Share by Manufacturers (2020-2025)
Table 7:Global Mebeverine Sales by Manufacturers (K Units) & (2020-2025)
Table 8:Global Mebeverine Sales Market Share by Manufacturers
Table 9:Global Mebeverine Average Sales Price (US$/Unit) of Manufacturers (2020-2025)
Table 10:Global Mebeverine Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
Table 11:Global Mebeverine Key Manufacturers Manufacturing Sites & Headquarters
Table 12:Global Mebeverine Manufacturers, Product Type & Application
Table 13:Global Mebeverine Manufacturers Establishment Date
Table 14:Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15:Global Mebeverine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2024)
Table 16:Major Manufacturers of Capsule
Table 17:Major Manufacturers of Tablet
Table 18:Global Mebeverine Sales by Type 2020 VS 2024 VS 2031 (K Units)
Table 19:Global Mebeverine Sales by Type (2020-2025) & (K Units)
Table 20:Global Mebeverine Sales by Type (2026-2031) & (K Units)
Table 21:Global Mebeverine Sales Market Share by Type (2020-2025)
Table 22:Global Mebeverine Sales Market Share by Type (2026-2031)
Table 23:Global Mebeverine Revenue by Type 2020 VS 2024 VS 2031 (K Units)
Table 24:Global Mebeverine Revenue by Type (2020-2025) & (K Units)
Table 25:Global Mebeverine Revenue by Type (2026-2031) & (K Units)
Table 26:Global Mebeverine Revenue Market Share by Type (2020-2025)
Table 27:Global Mebeverine Revenue Market Share by Type (2026-2031)
Table 28:Major Manufacturers of On-line
Table 29:Major Manufacturers of Drug Store
Table 30:Major Manufacturers of Hospital
Table 31:Global Mebeverine Sales by Application 2020 VS 2024 VS 2031 (K Units)
Table 32:Global Mebeverine Sales by Application (2020-2025) & (K Units)
Table 33:Global Mebeverine Sales by Application (2026-2031) & (K Units)
Table 34:Global Mebeverine Sales Market Share by Application (2020-2025)
Table 35:Global Mebeverine Sales Market Share by Application (2026-2031)
Table 36:Global Mebeverine Revenue by Application 2020 VS 2024 VS 2031 (K Units)
Table 37:Global Mebeverine Revenue by Application (2020-2025) & (K Units)
Table 38:Global Mebeverine Revenue by Application (2026-2031) & (K Units)
Table 39:Global Mebeverine Revenue Market Share by Application (2020-2025)
Table 40:Global Mebeverine Revenue Market Share by Application (2026-2031)
Table 41:Global Mebeverine Sales by Region: 2020 VS 2024 VS 2031 (K Units)
Table 42:Global Mebeverine Sales by Region (2020-2025) & (K Units)
Table 43:Global Mebeverine Sales Market Share by Region (2020-2025)
Table 44:Global Mebeverine Sales Forecasted by Region (2026-2031) & (K Units)
Table 45:Global Mebeverine Sales Forecasted Market Share by Region (2026-2031)
Table 46:North America Mebeverine Sales Growth Rate by Country: 2020 VS 2024 VS 2031 (K Units)
Table 47:North America Mebeverine Sales by Country (2020-2025) & (K Units)
Table 48:North America Mebeverine Sales by Country (2026-2031) & (K Units)
Table 49:Europe Mebeverine Sales Growth Rate by Country: 2020 VS 2024 VS 2031 (K Units)
Table 50:Europe Mebeverine Sales by Country (2020-2025) & (K Units)
Table 51:Europe Mebeverine Sales by Country (2026-2031) & (K Units)
Table 52:Asia Pacific Mebeverine Sales Growth Rate by Country: 2020 VS 2024 VS 2031 (K Units)
Table 53:Asia Pacific Mebeverine Sales by Country (2020-2025) & (K Units)
Table 54:Asia Pacific Mebeverine Sales by Country (2026-2031) & (K Units)
Table 55:South America, Middle East and Africa Mebeverine Sales Growth Rate by Country: 2020 VS 2024 VS 2031 (K Units)
Table 56:South America, Middle East and Africa Mebeverine Sales by Country (2020-2025) & (K Units)
Table 57:South America, Middle East and Africa Mebeverine Sales by Country (2026-2031) & (K Units)
Table 58:Global Mebeverine Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 59:Global Mebeverine Revenue by Region (2020-2025) & (US$ Million)
Table 60:Global Mebeverine Revenue by Region (2026-2031) & (US$ Million)
Table 61:Global Mebeverine Revenue Market Share by Region (2020-2025)
Table 62:Global Mebeverine Revenue Market Share by Region (2026-2031)
Table 63:Aurovitas Pharma Company Information
Table 64:Aurovitas Pharma Business Overview
Table 65:Aurovitas Pharma Mebeverine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2020-2025)
Table 66:Aurovitas Pharma Mebeverine Product Portfolio
Table 67:Aurovitas Pharma Recent Development
Table 68:Berlin Pharmaceutical Company Information
Table 69:Berlin Pharmaceutical Business Overview
Table 70:Berlin Pharmaceutical Mebeverine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2020-2025)
Table 71:Berlin Pharmaceutical Mebeverine Product Portfolio
Table 72:Berlin Pharmaceutical Recent Development
Table 73:Dr. Reddy's Company Information
Table 74:Dr. Reddy's Business Overview
Table 75:Dr. Reddy's Mebeverine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2020-2025)
Table 76:Dr. Reddy's Mebeverine Product Portfolio
Table 77:Dr. Reddy's Recent Development
Table 78:Eipico Pharmaceutical Company Information
Table 79:Eipico Pharmaceutical Business Overview
Table 80:Eipico Pharmaceutical Mebeverine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2020-2025)
Table 81:Eipico Pharmaceutical Mebeverine Product Portfolio
Table 82:Eipico Pharmaceutical Recent Development
Table 83:Expanscience Company Information
Table 84:Expanscience Business Overview
Table 85:Expanscience Mebeverine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2020-2025)
Table 86:Expanscience Mebeverine Product Portfolio
Table 87:Expanscience Recent Development
Table 88:Greville Investing Limited Company Information
Table 89:Greville Investing Limited Business Overview
Table 90:Greville Investing Limited Mebeverine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2020-2025)
Table 91:Greville Investing Limited Mebeverine Product Portfolio
Table 92:Greville Investing Limited Recent Development
Table 93:Pharco Company Information
Table 94:Pharco Business Overview
Table 95:Pharco Mebeverine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2020-2025)
Table 96:Pharco Mebeverine Product Portfolio
Table 97:Pharco Recent Development
Table 98:Puren Pharma Company Information
Table 99:Puren Pharma Business Overview
Table 100:Puren Pharma Mebeverine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2020-2025)
Table 101:Puren Pharma Mebeverine Product Portfolio
Table 102:Puren Pharma Recent Development
Table 103:Sopharma Company Information
Table 104:Sopharma Business Overview
Table 105:Sopharma Mebeverine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2020-2025)
Table 106:Sopharma Mebeverine Product Portfolio
Table 107:Sopharma Recent Development
Table 108:Swiss Pharm Company Information
Table 109:Swiss Pharm Business Overview
Table 110:Swiss Pharm Mebeverine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2020-2025)
Table 111:Swiss Pharm Mebeverine Product Portfolio
Table 112:Swiss Pharm Recent Development
Table 113:USV Private Limited Company Information
Table 114:USV Private Limited Business Overview
Table 115:USV Private Limited Mebeverine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2020-2025)
Table 116:USV Private Limited Mebeverine Product Portfolio
Table 117:USV Private Limited Recent Development
Table 118:Mylan Company Information
Table 119:Mylan Business Overview
Table 120:Mylan Mebeverine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2020-2025)
Table 121:Mylan Mebeverine Product Portfolio
Table 122:Mylan Recent Development
Table 123:Abbott Company Information
Table 124:Abbott Business Overview
Table 125:Abbott Mebeverine Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2020-2025)
Table 126:Abbott Mebeverine Product Portfolio
Table 127:Abbott Recent Development
Table 128:Key Raw Materials
Table 129:Raw Materials Key Suppliers
Table 130:Mebeverine Distributors List
Table 131:Mebeverine Customers List
Table 132:Research Programs/Design for This Report
Table 133:Authors List of This Report
Table 134:Secondary Sources
Table 135:Primary Sources
Figure 1:Mebeverine Product Image
Figure 2:Global Mebeverine Market Size (US$ Million), 2020 VS 2024 VS 2031
Figure 3:Global Mebeverine Market Size (2020-2031) & (US$ Million)
Figure 4:Global Mebeverine Sales (2020-2031) & (K Units)
Figure 5:Global Mebeverine Average Price (US$/Unit) & (2020-2031)
Figure 6:Global Top 5 and 10 Mebeverine Players Market Share by Revenue in 2023
Figure 7:Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8:Capsule Image
Figure 9:Tablet Image
Figure 10:Global Mebeverine Sales by Type (2020 VS 2024 VS 2031) & (K Units)
Figure 11:Global Mebeverine Sales Market Share 2020 VS 2024 VS 2031
Figure 12:Global Mebeverine Sales Market Share by Type (2020-2031)
Figure 13:Global Mebeverine Revenue by Type (2020 VS 2024 VS 2031) & (K Units)
Figure 14:Global Mebeverine Revenue Market Share 2020 VS 2024 VS 2031
Figure 15:Global Mebeverine Revenue Market Share by Type (2020-2031)
Figure 16:On-line Image
Figure 17:Drug Store Image
Figure 18:Hospital Image
Figure 19:Global Mebeverine Sales by Application (2020 VS 2024 VS 2031) & (K Units)
Figure 20:Global Mebeverine Sales Market Share 2020 VS 2024 VS 2031
Figure 21:Global Mebeverine Sales Market Share by Application (2020-2031)
Figure 22:Global Mebeverine Revenue by Application (2020 VS 2024 VS 2031) & (K Units)
Figure 23:Global Mebeverine Revenue Market Share 2020 VS 2024 VS 2031
Figure 24:Global Mebeverine Revenue Market Share by Application (2020-2031)
Figure 25:North America Mebeverine Sales and Growth Rate (2020-2031) & (K Units)
Figure 26:North America Mebeverine Sales Market Share by Country (2020-2031)
Figure 27:U.S. Mebeverine Sales and Growth Rate (2020-2031) & (K Units)
Figure 28:Canada Mebeverine Sales and Growth Rate (2020-2031) & (K Units)
Figure 29:Mexico Mebeverine Sales and Growth Rate (2020-2031) & (K Units)
Figure 30:Europe Mebeverine Sales and Growth Rate (2020-2031) & (K Units)
Figure 31:Europe Mebeverine Sales Market Share by Country (2020-2031)
Figure 32:Germany Mebeverine Sales and Growth Rate (2020-2031) & (K Units)
Figure 33:France Mebeverine Sales and Growth Rate (2020-2031) & (K Units)
Figure 34:U.K. Mebeverine Sales and Growth Rate (2020-2031) & (K Units)
Figure 35:Italy Mebeverine Sales and Growth Rate (2020-2031) & (K Units)
Figure 36:Netherlands Mebeverine Sales and Growth Rate (2020-2031) & (K Units)
Figure 37:Asia Pacific Mebeverine Sales and Growth Rate (2020-2031) & (K Units)
Figure 38:Asia Pacific Mebeverine Sales Market Share by Country (2020-2031)
Figure 39:China Mebeverine Sales and Growth Rate (2020-2031) & (K Units)
Figure 40:Japan Mebeverine Sales and Growth Rate (2020-2031) & (K Units)
Figure 41:South Korea Mebeverine Sales and Growth Rate (2020-2031) & (K Units)
Figure 42:Southeast Asia Mebeverine Sales and Growth Rate (2020-2031) & (K Units)
Figure 43:India Mebeverine Sales and Growth Rate (2020-2031) & (K Units)
Figure 44:Australia Mebeverine Sales and Growth Rate (2020-2031) & (K Units)
Figure 45:South America, Middle East and Africa Mebeverine Sales and Growth Rate (2020-2031) & (K Units)
Figure 46:South America, Middle East and Africa Mebeverine Sales Market Share by Country (2020-2031)
Figure 47:Brazil Mebeverine Sales and Growth Rate (2020-2031) & (K Units)
Figure 48:South Africa Mebeverine Sales and Growth Rate (2020-2031) & (K Units)
Figure 49:Saudi Arabia Mebeverine Sales and Growth Rate (2020-2031) & (K Units)
Figure 50:Turkey Mebeverine Sales and Growth Rate (2020-2031) & (K Units)
Figure 51:Argentina Mebeverine Sales and Growth Rate (2020-2031) & (K Units)
Figure 52:UAE Mebeverine Sales and Growth Rate (2020-2031) & (K Units)
Figure 53:Egypt Mebeverine Sales and Growth Rate (2020-2031) & (K Units)
Figure 54:Chile Mebeverine Sales and Growth Rate (2020-2031) & (K Units)
Figure 55:Global Mebeverine Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 56:Global Mebeverine Revenue Market Share by Region in Percentage: 2023 Versus 2030
Figure 57:North America Mebeverine Revenue (2020-2031) & (US$ Million)
Figure 58:North America Mebeverine Revenue Share by Country: 2020 VS 2024 VS 2031
Figure 59:Europe Mebeverine Revenue (2020-2031) & (US$ Million)
Figure 60:Europe Mebeverine Revenue Share by Country: 2020 VS 2024 VS 2031
Figure 61:Asia-Pacific Mebeverine Revenue (2020-2031) & (US$ Million)
Figure 62:Asia-Pacific Mebeverine Revenue Share by Country: 2020 VS 2024 VS 2031
Figure 63:South America, Middle East and Africa Mebeverine Revenue (2020-2031) & (US$ Million)
Figure 64:South America, Middle East and Africa Mebeverine Revenue Share by Country: 2020 VS 2024 VS 2031
Figure 65:Mebeverine Value Chain
Figure 66:Manufacturing Cost Structure
Figure 67:Mebeverine Production Mode & Process
Figure 68:Direct Comparison with Distribution Share
Figure 69:Distributors Profiles
Figure 70:Years Considered
Figure 71:Research Process
Figure 72:Key Executives Interviewed

Request a Sample

Sample excerpt is intended to facilitate an informed purchase decision. Its purpose is not to offer free information or act as a substitute for the comprehensive product. In order to tailor the sample to your specific requirements, we will reach out to you to gather more details about your criteria.

Report Cover

Pharma & Healthcare

Global Mebeverine Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

0| 0 Reviews

Pages: 193

Complete Your Request

Select Country
Phone

Customer reviews

  • starstarstarstarstar
  • 0 out of 5
  • 0 Reviews

5

star rating

4

star rating

3

star rating

2

star rating

1

star rating

No Rating Review Exist.

Write Review
  • starstarstarstarstar

Suggested Report

View More

No data found.